Kristi Gillette, DO
Internal Medicine · Quincy, ILNPI 1386999001
Payments from drug & device makers
What this record shows
This record is dominated by education: $547 of the $687 with a category attached, or 79.7%. Painteq LLC accounts for 79.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $547 and has fallen 94.7% since, to $29 in 2025.
Across 9 payments — averaging $76.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Painteq LLC$547
- AstraZeneca$38
- Scpharmaceuticals Inc.$29
- Karyopharm Therapeutics Inc.$24
- Pfizer$18
- Sobi, Inc$18
- plus $12 from 1 others
What the payments were for
- Food & beverage$13920%
- Education$54780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Painteq LLC | 2 | $547 |
| AstraZeneca | 2 | $38 |
| Scpharmaceuticals Inc. | 1 | $29 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Pfizer | 1 | $18 |
| Sobi, Inc | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAINTEQ$507
How this compares
$687 in reported general payments places this provider in the 70th percentile of 5,182 internal medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 11 | $2,248 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $1,080 |
| Gabapentin | 43 | $532 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $369 |
| Cetirizine Hcl | 15 | $236 |
| Fluticasone Propionate | 11 | $71 |
| Prednisone | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Quincy
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.